@article{legouill:hal-03012903,
TITLE = {Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group},
AUTHOR = {Le Gouill, Steven and Beldi-Ferchiou, Asma and Alcantara, Marion and Cacheux, Victoria and Safar, Violaine and Burroni, Barbara and Guidez, St{\'e}phanie and Gastinne, Thomas and Canioni, Danielle and Thieblemont, Catherine and Maisonneuve, Herv{\'e} and Bodet-Milin, Caroline and Houot, Roch and Oberic, Lucie and Bouabdallah, Krimo and Bescond, Charles and Damaj, Ghandi and Jaccard, Arnaud and Daguindau, Nicolas and Moreau, Anne and Tilly, Herv{\'e} and Ribrag, Vincent and Delfau-Larue, M.-H. and Hermine, Olivier and Macintyre, Elizabeth},
URL = {https://hal.science/hal-03012903},
JOURNAL = {Lancet Haematology},
PUBLISHER = {Elsevier},
VOLUME = {7},
NUMBER = {11},
PAGES = {e798-e807},
YEAR = {2020},
MONTH = Nov, DOI = {10.1016/S2352-3026(20)30291-X},
PDF = {https://hal.science/hal-03012903/file/S235230262030291X.pdf},
HAL_ID = {hal-03012903},
HAL_VERSION = {v1},
}